title: Japanese patients equally likely to benefit from aprepitant for chemotherapy-induced nausea and vomiting prevention.
authors.forename: João Paulo
authors.initials: JP
authors.lastname: da Silveira Nogueira Lima
authors.forename: Ricardo Akiyoshi
authors.initials: RA
authors.lastname: Nakamura
authors.forename: Lucas Vieira
authors.initials: LV
authors.lastname: dos Santos
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077608:Aprepitant; D044466:Asian People; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents; D009025:Morpholines; D000077608:Aprepitant